Board Change | 31-Jan-2024 | 07:00 | RNS |
Trading Update | 22-Jan-2024 | 07:00 | RNS |
Holding(s) in Company | 19-Jan-2024 | 15:00 | RNS |
Mevalone Approval in the State of California | 09-Jan-2024 | 07:01 | RNS |
Ecovelexâ„¢2023 Approval in Italy | 18-Dec-2023 | 07:00 | RNS |
Change of Nominated Adviser and Broker | 01-Nov-2023 | 07:00 | RNS |
Holding(s) in Company | 09-Oct-2023 | 16:44 | RNS |
Holding(s) in Company | 09-Oct-2023 | 16:39 | RNS |
Holding(s) in Company | 09-Oct-2023 | 12:46 | RNS |
Completion of Conditional Placing | 05-Oct-2023 | 07:00 | RNS |
Half Yearly Report | 29-Sep-2023 | 07:01 | RNS |
Capital Raising Update | 29-Sep-2023 | 07:00 | RNS |
Grant of Awards under Long-Term Incentive Plan | 31-Aug-2023 | 18:25 | RNS |
Result of GM and Capital Raising update | 17-Aug-2023 | 09:27 | RNS |
First Order For Ecovelex | 16-Aug-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 4.47p |
Change Today | -0.083p |
% Change | -1.83 % |
52 Week High | 11.85 |
52 Week Low | 3.20 |
Volume | 0 |
Shares Issued | 533.35m |
Market Cap | £23.82m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
CFO | Alexander John Abrey |
CEO | Sean M. Smith |
You are here: research